{"gene":"ARF3","run_date":"2026-06-09T22:02:44","timeline":{"discoveries":[{"year":1996,"finding":"A BFA-inhibited guanine nucleotide exchange protein (GEP) for ARF1 and ARF3 was purified from bovine brain cytosol as a ~200 kDa protein containing tryptic peptides 47% identical to yeast Sec7, establishing that ARF3 GDP-to-GTP exchange is catalyzed by a Sec7-domain-containing GEP and is sensitive to brefeldin A.","method":"Protein purification from bovine brain cytosol (DEAE-Sephacel, hydroxylapatite, Mono Q, Superose 6), SDS/PAGE, silver staining, electroelution/renaturation, in vitro nucleotide exchange activity assay, tryptic peptide sequencing","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro enzymatic activity reconstituted after purification with peptide-sequence identification; BFA sensitivity directly demonstrated","pmids":["8917509"],"is_preprint":false},{"year":2000,"finding":"Three residues of human ARF3 (F51, W66, Y81) form a hydrophobic pocket in the GDP-bound state; mutations at these residues increased the rate of GDP dissociation and association but not GTPγS binding, and selectively impaired binding to different ARF effectors in two-hybrid assays, indicating these residues regulate nucleotide exchange kinetics and effector interactions.","method":"Site-directed mutagenesis of ARF3, in vitro nucleotide dissociation/association assays, yeast two-hybrid effector binding assays","journal":"FEBS letters","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro biochemical assay combined with mutagenesis and two-hybrid binding analysis in single study","pmids":["11150519"],"is_preprint":false},{"year":2010,"finding":"ARF3 localizes selectively to the trans-Golgi network (TGN) in a manner uniquely dependent on BIG family guanine nucleotide exchange factors; BIGs knockdown redistributes ARF3 but not ARF1 from Golgi membranes, and this TGN association is temperature-sensitive. Mutational analysis identified pairs of residues at opposite ends of ARF3 that separately control membrane recruitment and temperature-dependent release.","method":"siRNA knockdown of BIG GEFs, fluorescence microscopy, temperature-shift experiments (20°C block), site-directed mutagenesis of ARF3, phylogenetic analysis","journal":"Molecular biology of the cell","confidence":"High","confidence_rationale":"Tier 2 / Moderate — reciprocal knockdown with localization readout, mutagenesis dissecting two distinct properties, multiple orthogonal approaches in one study","pmids":["20357002"],"is_preprint":false},{"year":2012,"finding":"ARF1 and ARF3 localize to endosomal compartments containing endocytosed transferrin, and simultaneous siRNA depletion of both ARF1 and ARF3 induces tubulation of recycling endosomes (Rab4+, Rab11+, TfR+) and suppresses transferrin recycling to the plasma membrane, without affecting Golgi integrity, early/late endosomes, or retrograde TGN transport.","method":"siRNA double knockdown of ARF1 and ARF3, EGFP-tagging and fluorescence microscopy, transferrin recycling assay, endocytosis assay, retrograde transport assays (TGN38, CD4-furin, EGF)","journal":"Cell structure and function","confidence":"High","confidence_rationale":"Tier 2 / Moderate — clean double knockdown with multiple specific functional readouts and appropriate negative controls, single lab","pmids":["22971977"],"is_preprint":false},{"year":2015,"finding":"Class I ARFs (ARF1 and ARF3) localize to the Flemming body during late cytokinesis; double knockdown of ARF1 and ARF3 increases multinucleate cells, and simultaneous triple knockdown of ARF1, ARF3, and ARF6 causes severe cytokinesis defects. EFA6 exchange factor activates both ARF6 and ARF1 in cells.","method":"siRNA knockdown (double and triple), fluorescence microscopy of Flemming body localization, multinucleate cell quantification, cytokinesis assays","journal":"Journal of biochemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct localization with siRNA loss-of-function and phenotypic readout; ARF3-specific contribution partially confounded by combined knockdowns","pmids":["26330566"],"is_preprint":false},{"year":2020,"finding":"BIG1 (a BFA-inhibited GEF) activates ARF3 in macrophages; BIG1 deficiency inhibits ARF3 activation, reduces PI(4,5)P2 synthesis by impairing PIP5K activation, and prevents TIRAP recruitment to the plasma membrane, thereby suppressing TLR4-MyD88 signaling during LPS stimulation.","method":"Myeloid-specific BIG1 knockout mouse, siRNA knockdown in bone marrow-derived macrophages and THP-1 cells, ARF3 activation assay, PI(4,5)P2 measurement, TIRAP recruitment assay, cytokine measurement","journal":"Cell death & disease","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic KO plus cell-based knockdown with pathway readouts; ARF3 activation shown as downstream of BIG1 but direct ARF3 KO epistasis not shown independently","pmids":["32415087"],"is_preprint":false},{"year":2021,"finding":"De novo missense variants in ARF3 (p.Asp67Val and p.Arg99Leu) cause neurodevelopmental disorder. In vitro assays showed p.Asp67Val causes cytosolic dispersal of ARF3 and dispersed Golgi (loss-of-function), while p.Arg99Leu localizes normally to Golgi but shows increased binding to GGA1 (gain-of-function). In vivo, p.Asp67Val expression was lethal in Drosophila, and p.Arg99Leu caused rough eye phenotype similar to known gain-of-function variant p.Gln71Leu.","method":"In vitro subcellular localization assays, pull-down assays for GGA1 binding, Drosophila in vivo expression experiments","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — biochemical pull-down combined with localization assays and in vivo Drosophila phenotyping with multiple variants, single study","pmids":["34346499"],"is_preprint":false},{"year":2022,"finding":"De novo missense variants in ARF3 affecting the guanine nucleotide binding pocket variably perturb protein stability and GTP/GDP binding, disrupt Golgi morphology and vesicle assembly/trafficking in cell-based assays, and in zebrafish models cause dominant effects on brain size (microcephaly) and body plan formation, impairing neural precursor proliferation and planar cell polarity-dependent cell movements.","method":"Cell-based assays (Golgi morphology, vesicle trafficking), nucleotide binding assays, zebrafish disease modeling, in vivo analysis of neural precursor proliferation and cell polarity","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — multiple orthogonal methods (biochemical, cell-based, in vivo vertebrate model) across multiple variants; independently corroborates PMID 34346499","pmids":["36369169"],"is_preprint":false},{"year":2023,"finding":"ARF3 controls the modality of collective cancer cell invasion by associating with and regulating the turnover of N-cadherin; ARF3 loss or gain switches between leader-cell-led chain invasion and collective sheet movement. In vivo, ARF3 levels act as a rheostat for metastasis from intraprostatic tumor transplants.","method":"Functional genomic screen of 3D prostate cancer cell behavior, siRNA/overexpression, N-cadherin co-association and turnover assays, intraprostatic in vivo tumor transplant model","journal":"The Journal of cell biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — 3D functional screen plus mechanistic follow-up on N-cadherin association and in vivo metastasis; single lab study","pmids":["36880595"],"is_preprint":false},{"year":2025,"finding":"ARF3 knockdown in mice and cells suppressed influenza A virus (H3N2) replication in vitro and mitigated IAV-induced lung injury in vivo, reducing pro-inflammatory cytokines and attenuating NLRP3 inflammasome activation.","method":"siRNA knockdown in vitro, mouse IAV pneumonia model, cytokine measurement, NLRP3 inflammasome activation assay","journal":"Virus genes","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single lab, no direct biochemical mechanism linking ARF3 to inflammasome; phenotypic knockdown with limited pathway resolution","pmids":["40608252"],"is_preprint":false}],"current_model":"Human ARF3 is a small GTPase that cycles between GDP-bound (inactive) and GTP-bound (active) states catalyzed by BIG family Sec7-domain GEFs (including BIG1 and BIG2) in a brefeldin A-sensitive manner; it localizes selectively to the trans-Golgi network and recycling endosomes, where it is redundantly required with ARF1 for recycling endosome integrity and transferrin recycling to the plasma membrane, participates in cytokinesis at the Flemming body, and regulates Golgi vesicle trafficking—as demonstrated by disease-causing variants that perturb GTP/GDP binding, Golgi morphology, and brain development; additionally, ARF3 controls collective cancer cell invasion modality by regulating N-cadherin turnover, and acts downstream of BIG1 to synthesize PI(4,5)P2 and facilitate TLR4-MyD88 inflammatory signaling."},"narrative":{"mechanistic_narrative":"ARF3 is a small GTPase that cycles between inactive GDP-bound and active GTP-bound states to govern membrane trafficking at the trans-Golgi network and recycling endosomes [PMID:8917509, PMID:20357002, PMID:22971977]. Its activation is catalyzed by Sec7-domain, brefeldin A-inhibited guanine nucleotide exchange factors of the BIG family purified from brain cytosol, and ARF3 depends uniquely on BIG GEFs for its temperature-sensitive recruitment to TGN membranes, distinguishing it from the closely related ARF1 [PMID:8917509, PMID:20357002]. A hydrophobic pocket formed by F51, W66, and Y81 in the GDP-bound state, together with residues at opposite ends of the protein, tunes nucleotide exchange kinetics, membrane recruitment, and effector selection [PMID:11150519, PMID:20357002]. Functionally, ARF3 acts redundantly with ARF1 to maintain recycling endosome integrity and transferrin recycling to the plasma membrane, and both class I ARFs localize to the Flemming body where they are required for completion of cytokinesis [PMID:22971977, PMID:26330566]. ARF3 also controls collective cancer cell invasion modality and metastatic behavior by associating with and regulating turnover of N-cadherin [PMID:36880595], and acts downstream of BIG1 in macrophages to drive PI(4,5)P2 synthesis and TIRAP recruitment that support TLR4-MyD88 inflammatory signaling [PMID:32415087]. De novo missense variants in ARF3 that perturb GTP/GDP binding, GGA1 effector binding, and Golgi morphology cause a neurodevelopmental disorder, with both loss-of-function and gain-of-function alleles disrupting brain development in zebrafish and Drosophila models [PMID:34346499, PMID:36369169].","teleology":[{"year":1996,"claim":"Established that ARF3 nucleotide exchange is not spontaneous but catalyzed by a defined enzyme class, identifying a Sec7-domain GEP as the activator and explaining the brefeldin A sensitivity of ARF3-dependent trafficking.","evidence":"Protein purification of a ~200 kDa GEP from bovine brain cytosol with in vitro nucleotide exchange assays and tryptic peptide sequencing showing 47% identity to yeast Sec7","pmids":["8917509"],"confidence":"High","gaps":["Did not resolve which specific BIG-family GEF acts on ARF3 in cells","Substrate specificity between ARF1 and ARF3 not distinguished"]},{"year":2000,"claim":"Defined the structural determinants within ARF3 that control nucleotide exchange kinetics and effector binding, linking specific GDP-pocket residues to functional output.","evidence":"Site-directed mutagenesis of F51/W66/Y81 with in vitro nucleotide dissociation/association assays and yeast two-hybrid effector binding","pmids":["11150519"],"confidence":"High","gaps":["Effector identities defined only by two-hybrid, not in cells","No structural model of the GDP-bound pocket provided"]},{"year":2010,"claim":"Resolved how ARF3 is targeted to a specific membrane compartment, showing its TGN localization uniquely requires BIG GEFs and is governed by distinct residues controlling recruitment versus temperature-dependent release.","evidence":"siRNA knockdown of BIG GEFs with fluorescence microscopy, temperature-shift block, and ARF3 mutagenesis","pmids":["20357002"],"confidence":"High","gaps":["Mechanism of temperature-dependent release not molecularly defined","Functional consequence of ARF3-specific TGN targeting not addressed here"]},{"year":2012,"claim":"Assigned ARF3 a functional role in endosomal recycling, showing it acts redundantly with ARF1 to maintain recycling endosome morphology and transferrin return to the plasma membrane.","evidence":"siRNA double knockdown of ARF1 and ARF3 with transferrin recycling, endocytosis, and retrograde transport assays plus compartment markers","pmids":["22971977"],"confidence":"High","gaps":["Redundancy prevents isolation of the ARF3-specific contribution","Effectors mediating recycling endosome integrity not identified"]},{"year":2015,"claim":"Extended ARF3 function to cell division, demonstrating class I ARFs localize to the Flemming body and are required for cytokinesis completion.","evidence":"Double and triple siRNA knockdown with Flemming body localization and multinucleate cell quantification","pmids":["26330566"],"confidence":"Medium","gaps":["ARF3-specific contribution confounded by combined knockdowns","Molecular partners at the Flemming body not identified"]},{"year":2020,"claim":"Placed ARF3 in an inflammatory signaling axis, showing BIG1-driven ARF3 activation promotes PI(4,5)P2 synthesis and TIRAP recruitment supporting TLR4-MyD88 signaling.","evidence":"Myeloid-specific BIG1 knockout mouse and macrophage knockdowns with ARF3 activation, PI(4,5)P2, TIRAP recruitment, and cytokine assays","pmids":["32415087"],"confidence":"Medium","gaps":["Direct ARF3 KO epistasis not shown","Mechanism linking ARF3 to PIP5K activation not biochemically resolved"]},{"year":2022,"claim":"Connected ARF3 dysfunction to human disease, showing de novo variants perturbing the nucleotide-binding pocket and effector binding cause a neurodevelopmental disorder via both loss- and gain-of-function mechanisms.","evidence":"Cell-based Golgi/vesicle and nucleotide binding assays, GGA1 pull-downs, and Drosophila and zebrafish disease modeling across multiple variants","pmids":["34346499","36369169"],"confidence":"High","gaps":["How distinct alleles produce convergent neurodevelopmental phenotypes unresolved","Cell-type-specific requirements in human brain not defined"]},{"year":2023,"claim":"Revealed a role for ARF3 in cancer cell behavior, identifying N-cadherin turnover as the mechanism by which ARF3 levels set collective invasion modality and metastatic potential.","evidence":"3D functional genomic screen with siRNA/overexpression, N-cadherin co-association and turnover assays, and intraprostatic in vivo tumor transplants","pmids":["36880595"],"confidence":"Medium","gaps":["Direct physical mode of ARF3-N-cadherin association not structurally defined","Single-lab study not independently replicated"]},{"year":2025,"claim":"Implicated ARF3 in viral pathogenesis, showing its knockdown suppresses influenza A replication and dampens inflammasome-driven lung injury.","evidence":"siRNA knockdown in vitro and mouse IAV pneumonia model with cytokine and NLRP3 inflammasome readouts","pmids":["40608252"],"confidence":"Low","gaps":["No direct biochemical mechanism linking ARF3 to NLRP3 inflammasome","Single-lab phenotypic study with limited pathway resolution"]},{"year":null,"claim":"How ARF3's distinct membrane localization and effector selectivity translate into its non-redundant roles in neurodevelopment, cancer invasion, and inflammation remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No structure of ARF3 with its GEFs or effectors in the timeline","ARF3-specific (vs ARF1) effector repertoire not comprehensively mapped","Causal chain from GTPase cycle to PI(4,5)P2 synthesis and N-cadherin turnover not biochemically reconstituted"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0003924","term_label":"GTPase activity","supporting_discovery_ids":[0,1,7]}],"localization":[{"term_id":"GO:0005794","term_label":"Golgi apparatus","supporting_discovery_ids":[2,6,7]},{"term_id":"GO:0005768","term_label":"endosome","supporting_discovery_ids":[3]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[6]}],"pathway":[{"term_id":"R-HSA-5653656","term_label":"Vesicle-mediated transport","supporting_discovery_ids":[2,3]},{"term_id":"R-HSA-1640170","term_label":"Cell Cycle","supporting_discovery_ids":[4]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[5]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[6,7]}],"complexes":[],"partners":["BIG1","GGA1","N-CADHERIN"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P61204","full_name":"ADP-ribosylation factor 3","aliases":[],"length_aa":181,"mass_kda":20.6,"function":"GTP-binding protein that functions as an allosteric activator of the cholera toxin catalytic subunit, an ADP-ribosyltransferase. Involved in protein trafficking; may modulate vesicle budding and uncoating within the Golgi apparatus","subcellular_location":"Golgi apparatus; Cytoplasm, perinuclear region","url":"https://www.uniprot.org/uniprotkb/P61204/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/ARF3","classification":"Not Classified","n_dependent_lines":27,"n_total_lines":1208,"dependency_fraction":0.022350993377483443},"opencell":{"profiled":true,"resolved_as":"","ensg_id":"ENSG00000134287","cell_line_id":"CID000654","localizations":[{"compartment":"cytoplasmic","grade":3},{"compartment":"golgi","grade":3},{"compartment":"nucleoplasm","grade":3},{"compartment":"vesicles","grade":3}],"interactors":[],"url":"https://opencell.sf.czbiohub.org/target/CID000654","total_profiled":1310},"omim":[{"mim_id":"605928","title":"ADP-RIBOSYLATION FACTOR-INTERACTING PROTEIN 1; ARFIP1","url":"https://www.omim.org/entry/605928"},{"mim_id":"605926","title":"PROTEIN INTERACTING WITH C KINASE 1; PICK1","url":"https://www.omim.org/entry/605926"},{"mim_id":"604141","title":"ADP-RIBOSYLATION FACTOR GUANINE NUCLEOTIDE EXCHANGE FACTOR 1; ARFGEF1","url":"https://www.omim.org/entry/604141"},{"mim_id":"601638","title":"ADP-RIBOSYLATION FACTOR-INTERACTING PROTEIN 2; ARFIP2","url":"https://www.omim.org/entry/601638"},{"mim_id":"600732","title":"ADP-RIBOSYLATION FACTOR-LIKE GTPase 4D; ARL4D","url":"https://www.omim.org/entry/600732"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in all","driving_tissues":[{"tissue":"brain","ntpm":271.2}],"url":"https://www.proteinatlas.org/search/ARF3"},"hgnc":{"alias_symbol":[],"prev_symbol":[]},"alphafold":{"accession":"P61204","domains":[{"cath_id":"3.40.50.300","chopping":"73-178","consensus_level":"high","plddt":94.8799,"start":73,"end":178}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P61204","model_url":"https://alphafold.ebi.ac.uk/files/AF-P61204-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P61204-F1-predicted_aligned_error_v6.png","plddt_mean":86.12},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=ARF3","jax_strain_url":"https://www.jax.org/strain/search?query=ARF3"},"sequence":{"accession":"P61204","fasta_url":"https://rest.uniprot.org/uniprotkb/P61204.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P61204/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P61204"}},"corpus_meta":[{"pmid":"8917509","id":"PMC_8917509","title":"Isolation of a brefeldin A-inhibited guanine nucleotide-exchange protein for ADP ribosylation factor (ARF) 1 and ARF3 that contains a Sec7-like domain.","date":"1996","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/8917509","citation_count":131,"is_preprint":false},{"pmid":"28552357","id":"PMC_28552357","title":"The THO Complex Non-Cell-Autonomously Represses Female Germline Specification through the TAS3-ARF3 Module.","date":"2017","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/28552357","citation_count":76,"is_preprint":false},{"pmid":"22971977","id":"PMC_22971977","title":"ARF1 and ARF3 are required for the integrity of recycling endosomes and the recycling pathway.","date":"2012","source":"Cell structure and function","url":"https://pubmed.ncbi.nlm.nih.gov/22971977","citation_count":56,"is_preprint":false},{"pmid":"8063710","id":"PMC_8063710","title":"Characterization of a glucose-repressible ADP-ribosylation factor 3 (ARF3) from Saccharomyces cerevisiae.","date":"1994","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8063710","citation_count":50,"is_preprint":false},{"pmid":"20357002","id":"PMC_20357002","title":"Arf3 is activated uniquely at the trans-Golgi network by brefeldin A-inhibited guanine nucleotide exchange factors.","date":"2010","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/20357002","citation_count":48,"is_preprint":false},{"pmid":"33897748","id":"PMC_33897748","title":"Auxin Response Factor 2 (ARF2), ARF3, and ARF4 Mediate Both Lateral Root and Nitrogen Fixing Nodule Development in Medicago truncatula.","date":"2021","source":"Frontiers in plant science","url":"https://pubmed.ncbi.nlm.nih.gov/33897748","citation_count":32,"is_preprint":false},{"pmid":"35298645","id":"PMC_35298645","title":"Maize miR167-ARF3/30-polyamine oxidase 1 module-regulated H2O2 production confers resistance to maize chlorotic mottle virus.","date":"2022","source":"Plant physiology","url":"https://pubmed.ncbi.nlm.nih.gov/35298645","citation_count":31,"is_preprint":false},{"pmid":"23129621","id":"PMC_23129621","title":"Non-cell-autonomous regulation of crucifer self-incompatibility by Auxin Response Factor ARF3.","date":"2012","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/23129621","citation_count":30,"is_preprint":false},{"pmid":"26734029","id":"PMC_26734029","title":"MicroRNA390-Directed TAS3 Cleavage Leads to the Production of tasiRNA-ARF3/4 During Somatic Embryogenesis in Dimocarpus longan Lour.","date":"2015","source":"Frontiers in plant science","url":"https://pubmed.ncbi.nlm.nih.gov/26734029","citation_count":28,"is_preprint":false},{"pmid":"34346499","id":"PMC_34346499","title":"De novo ARF3 variants cause neurodevelopmental disorder with brain abnormality.","date":"2021","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/34346499","citation_count":22,"is_preprint":false},{"pmid":"17425670","id":"PMC_17425670","title":"The Saccharomyces cerevisiae Arf3 protein is involved in actin cable and cortical patch formation.","date":"2007","source":"FEMS yeast research","url":"https://pubmed.ncbi.nlm.nih.gov/17425670","citation_count":21,"is_preprint":false},{"pmid":"39659014","id":"PMC_39659014","title":"The long noncoding RNA ALEX1 confers a functional phase state of ARF3 to enhance rice resistance to bacterial pathogens.","date":"2024","source":"Molecular plant","url":"https://pubmed.ncbi.nlm.nih.gov/39659014","citation_count":21,"is_preprint":false},{"pmid":"26330566","id":"PMC_26330566","title":"Class I Arfs (Arf1 and Arf3) and Arf6 are localized to the Flemming body and play important roles in cytokinesis.","date":"2015","source":"Journal of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/26330566","citation_count":20,"is_preprint":false},{"pmid":"32415087","id":"PMC_32415087","title":"BIG1 controls macrophage pro-inflammatory responses through ARF3-mediated PI(4,5)P2 synthesis.","date":"2020","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/32415087","citation_count":20,"is_preprint":false},{"pmid":"36369169","id":"PMC_36369169","title":"Dominant ARF3 variants disrupt Golgi integrity and cause a neurodevelopmental disorder recapitulated in zebrafish.","date":"2022","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/36369169","citation_count":19,"is_preprint":false},{"pmid":"17786213","id":"PMC_17786213","title":"Identification of a guanine nucleotide exchange factor for Arf3, the yeast orthologue of mammalian Arf6.","date":"2007","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/17786213","citation_count":17,"is_preprint":false},{"pmid":"36880595","id":"PMC_36880595","title":"The small GTPase ARF3 controls invasion modality and metastasis by regulating N-cadherin levels.","date":"2023","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/36880595","citation_count":12,"is_preprint":false},{"pmid":"32240746","id":"PMC_32240746","title":"circ_ARF3 regulates the pathogenesis of osteosarcoma by sponging miR-1299 to maintain CDK6 expression.","date":"2020","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/32240746","citation_count":12,"is_preprint":false},{"pmid":"11150519","id":"PMC_11150519","title":"Residues forming a hydrophobic pocket in ARF3 are determinants of GDP dissociation and effector interactions.","date":"2000","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/11150519","citation_count":10,"is_preprint":false},{"pmid":"33847108","id":"PMC_33847108","title":"ARF3 inhibits proliferation and promotes apoptosis in gastric cancer by regulating AKT and ERK pathway.","date":"2021","source":"Acta biochimica Polonica","url":"https://pubmed.ncbi.nlm.nih.gov/33847108","citation_count":9,"is_preprint":false},{"pmid":"34447403","id":"PMC_34447403","title":"Genome-Wide Identification of the ARF Gene Family and ARF3 Target Genes Regulating Ovary Initiation in Hazel via ChIP Sequencing.","date":"2021","source":"Frontiers in plant science","url":"https://pubmed.ncbi.nlm.nih.gov/34447403","citation_count":9,"is_preprint":false},{"pmid":"39120858","id":"PMC_39120858","title":"CircRNA Arf3 suppresses glomerular mesangial cell proliferation and fibrosis in diabetic nephropathy via miR-107-3p/Tmbim6 axis.","date":"2024","source":"Journal of bioenergetics and biomembranes","url":"https://pubmed.ncbi.nlm.nih.gov/39120858","citation_count":5,"is_preprint":false},{"pmid":"41379936","id":"PMC_41379936","title":"ARF3-mediated auxin signaling is essential for sex determination in cucumber.","date":"2025","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/41379936","citation_count":4,"is_preprint":false},{"pmid":"37457110","id":"PMC_37457110","title":"A Novel Circ_Arf3/miR-452-5p/Mbnl1 Axis Regulates Proliferation and Expression of Fibrosis-Related Proteins of Mouse Mesangial Cells Under High Glucose.","date":"2023","source":"Diabetes, metabolic syndrome and obesity : targets and therapy","url":"https://pubmed.ncbi.nlm.nih.gov/37457110","citation_count":1,"is_preprint":false},{"pmid":"41507605","id":"PMC_41507605","title":"Newly identified ARF3 variants strengthen the causal link between Golgi fragmentation and brain malformations.","date":"2026","source":"European journal of human genetics : EJHG","url":"https://pubmed.ncbi.nlm.nih.gov/41507605","citation_count":1,"is_preprint":false},{"pmid":"38712921","id":"PMC_38712921","title":"Neurodevelopmental disorder associated with gene ARF3: A case report.","date":"2024","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/38712921","citation_count":1,"is_preprint":false},{"pmid":"36920439","id":"PMC_36920439","title":"ARF3 weights the balance for prostate cancer metastasis.","date":"2023","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/36920439","citation_count":1,"is_preprint":false},{"pmid":"41386637","id":"PMC_41386637","title":"The tasiR-ARF pathway in plants: origin, functions, and interplay of miR-390, tasiRNAs and ARF3.","date":"2025","source":"Plant biology (Stuttgart, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/41386637","citation_count":0,"is_preprint":false},{"pmid":"40608252","id":"PMC_40608252","title":"ARF3 knockdown inhibits influenza a virus and virus-induced pneumonia.","date":"2025","source":"Virus genes","url":"https://pubmed.ncbi.nlm.nih.gov/40608252","citation_count":0,"is_preprint":false},{"pmid":"39756487","id":"PMC_39756487","title":"ARF3 as a novel biomarker and target in acute myeloid leukemia: Insights from pan-cancer analysis.","date":"2025","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/39756487","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2024.09.02.610784","title":"ETTIN-mediated auxin signalling is an angiosperm-specific neofunctionalization for carpel development","date":"2024-09-02","source":"bioRxiv","url":"https://doi.org/10.1101/2024.09.02.610784","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":16422,"output_tokens":2864,"usd":0.046113,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":10202,"output_tokens":3351,"usd":0.067392,"stage2_stop_reason":"end_turn"},"total_usd":0.113505,"stage1_batch_id":"msgbatch_0179Z2pxRYBsXi2xADneafRw","stage2_batch_id":"msgbatch_01LaY9ZaVdgjWArcZo9eqQE5","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1996,\n      \"finding\": \"A BFA-inhibited guanine nucleotide exchange protein (GEP) for ARF1 and ARF3 was purified from bovine brain cytosol as a ~200 kDa protein containing tryptic peptides 47% identical to yeast Sec7, establishing that ARF3 GDP-to-GTP exchange is catalyzed by a Sec7-domain-containing GEP and is sensitive to brefeldin A.\",\n      \"method\": \"Protein purification from bovine brain cytosol (DEAE-Sephacel, hydroxylapatite, Mono Q, Superose 6), SDS/PAGE, silver staining, electroelution/renaturation, in vitro nucleotide exchange activity assay, tryptic peptide sequencing\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro enzymatic activity reconstituted after purification with peptide-sequence identification; BFA sensitivity directly demonstrated\",\n      \"pmids\": [\"8917509\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Three residues of human ARF3 (F51, W66, Y81) form a hydrophobic pocket in the GDP-bound state; mutations at these residues increased the rate of GDP dissociation and association but not GTPγS binding, and selectively impaired binding to different ARF effectors in two-hybrid assays, indicating these residues regulate nucleotide exchange kinetics and effector interactions.\",\n      \"method\": \"Site-directed mutagenesis of ARF3, in vitro nucleotide dissociation/association assays, yeast two-hybrid effector binding assays\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro biochemical assay combined with mutagenesis and two-hybrid binding analysis in single study\",\n      \"pmids\": [\"11150519\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"ARF3 localizes selectively to the trans-Golgi network (TGN) in a manner uniquely dependent on BIG family guanine nucleotide exchange factors; BIGs knockdown redistributes ARF3 but not ARF1 from Golgi membranes, and this TGN association is temperature-sensitive. Mutational analysis identified pairs of residues at opposite ends of ARF3 that separately control membrane recruitment and temperature-dependent release.\",\n      \"method\": \"siRNA knockdown of BIG GEFs, fluorescence microscopy, temperature-shift experiments (20°C block), site-directed mutagenesis of ARF3, phylogenetic analysis\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal knockdown with localization readout, mutagenesis dissecting two distinct properties, multiple orthogonal approaches in one study\",\n      \"pmids\": [\"20357002\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"ARF1 and ARF3 localize to endosomal compartments containing endocytosed transferrin, and simultaneous siRNA depletion of both ARF1 and ARF3 induces tubulation of recycling endosomes (Rab4+, Rab11+, TfR+) and suppresses transferrin recycling to the plasma membrane, without affecting Golgi integrity, early/late endosomes, or retrograde TGN transport.\",\n      \"method\": \"siRNA double knockdown of ARF1 and ARF3, EGFP-tagging and fluorescence microscopy, transferrin recycling assay, endocytosis assay, retrograde transport assays (TGN38, CD4-furin, EGF)\",\n      \"journal\": \"Cell structure and function\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean double knockdown with multiple specific functional readouts and appropriate negative controls, single lab\",\n      \"pmids\": [\"22971977\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Class I ARFs (ARF1 and ARF3) localize to the Flemming body during late cytokinesis; double knockdown of ARF1 and ARF3 increases multinucleate cells, and simultaneous triple knockdown of ARF1, ARF3, and ARF6 causes severe cytokinesis defects. EFA6 exchange factor activates both ARF6 and ARF1 in cells.\",\n      \"method\": \"siRNA knockdown (double and triple), fluorescence microscopy of Flemming body localization, multinucleate cell quantification, cytokinesis assays\",\n      \"journal\": \"Journal of biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct localization with siRNA loss-of-function and phenotypic readout; ARF3-specific contribution partially confounded by combined knockdowns\",\n      \"pmids\": [\"26330566\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"BIG1 (a BFA-inhibited GEF) activates ARF3 in macrophages; BIG1 deficiency inhibits ARF3 activation, reduces PI(4,5)P2 synthesis by impairing PIP5K activation, and prevents TIRAP recruitment to the plasma membrane, thereby suppressing TLR4-MyD88 signaling during LPS stimulation.\",\n      \"method\": \"Myeloid-specific BIG1 knockout mouse, siRNA knockdown in bone marrow-derived macrophages and THP-1 cells, ARF3 activation assay, PI(4,5)P2 measurement, TIRAP recruitment assay, cytokine measurement\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic KO plus cell-based knockdown with pathway readouts; ARF3 activation shown as downstream of BIG1 but direct ARF3 KO epistasis not shown independently\",\n      \"pmids\": [\"32415087\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"De novo missense variants in ARF3 (p.Asp67Val and p.Arg99Leu) cause neurodevelopmental disorder. In vitro assays showed p.Asp67Val causes cytosolic dispersal of ARF3 and dispersed Golgi (loss-of-function), while p.Arg99Leu localizes normally to Golgi but shows increased binding to GGA1 (gain-of-function). In vivo, p.Asp67Val expression was lethal in Drosophila, and p.Arg99Leu caused rough eye phenotype similar to known gain-of-function variant p.Gln71Leu.\",\n      \"method\": \"In vitro subcellular localization assays, pull-down assays for GGA1 binding, Drosophila in vivo expression experiments\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — biochemical pull-down combined with localization assays and in vivo Drosophila phenotyping with multiple variants, single study\",\n      \"pmids\": [\"34346499\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"De novo missense variants in ARF3 affecting the guanine nucleotide binding pocket variably perturb protein stability and GTP/GDP binding, disrupt Golgi morphology and vesicle assembly/trafficking in cell-based assays, and in zebrafish models cause dominant effects on brain size (microcephaly) and body plan formation, impairing neural precursor proliferation and planar cell polarity-dependent cell movements.\",\n      \"method\": \"Cell-based assays (Golgi morphology, vesicle trafficking), nucleotide binding assays, zebrafish disease modeling, in vivo analysis of neural precursor proliferation and cell polarity\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — multiple orthogonal methods (biochemical, cell-based, in vivo vertebrate model) across multiple variants; independently corroborates PMID 34346499\",\n      \"pmids\": [\"36369169\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"ARF3 controls the modality of collective cancer cell invasion by associating with and regulating the turnover of N-cadherin; ARF3 loss or gain switches between leader-cell-led chain invasion and collective sheet movement. In vivo, ARF3 levels act as a rheostat for metastasis from intraprostatic tumor transplants.\",\n      \"method\": \"Functional genomic screen of 3D prostate cancer cell behavior, siRNA/overexpression, N-cadherin co-association and turnover assays, intraprostatic in vivo tumor transplant model\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — 3D functional screen plus mechanistic follow-up on N-cadherin association and in vivo metastasis; single lab study\",\n      \"pmids\": [\"36880595\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"ARF3 knockdown in mice and cells suppressed influenza A virus (H3N2) replication in vitro and mitigated IAV-induced lung injury in vivo, reducing pro-inflammatory cytokines and attenuating NLRP3 inflammasome activation.\",\n      \"method\": \"siRNA knockdown in vitro, mouse IAV pneumonia model, cytokine measurement, NLRP3 inflammasome activation assay\",\n      \"journal\": \"Virus genes\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single lab, no direct biochemical mechanism linking ARF3 to inflammasome; phenotypic knockdown with limited pathway resolution\",\n      \"pmids\": [\"40608252\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"Human ARF3 is a small GTPase that cycles between GDP-bound (inactive) and GTP-bound (active) states catalyzed by BIG family Sec7-domain GEFs (including BIG1 and BIG2) in a brefeldin A-sensitive manner; it localizes selectively to the trans-Golgi network and recycling endosomes, where it is redundantly required with ARF1 for recycling endosome integrity and transferrin recycling to the plasma membrane, participates in cytokinesis at the Flemming body, and regulates Golgi vesicle trafficking—as demonstrated by disease-causing variants that perturb GTP/GDP binding, Golgi morphology, and brain development; additionally, ARF3 controls collective cancer cell invasion modality by regulating N-cadherin turnover, and acts downstream of BIG1 to synthesize PI(4,5)P2 and facilitate TLR4-MyD88 inflammatory signaling.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"ARF3 is a small GTPase that cycles between inactive GDP-bound and active GTP-bound states to govern membrane trafficking at the trans-Golgi network and recycling endosomes [#0, #2, #3]. Its activation is catalyzed by Sec7-domain, brefeldin A-inhibited guanine nucleotide exchange factors of the BIG family purified from brain cytosol, and ARF3 depends uniquely on BIG GEFs for its temperature-sensitive recruitment to TGN membranes, distinguishing it from the closely related ARF1 [#0, #2]. A hydrophobic pocket formed by F51, W66, and Y81 in the GDP-bound state, together with residues at opposite ends of the protein, tunes nucleotide exchange kinetics, membrane recruitment, and effector selection [#1, #2]. Functionally, ARF3 acts redundantly with ARF1 to maintain recycling endosome integrity and transferrin recycling to the plasma membrane, and both class I ARFs localize to the Flemming body where they are required for completion of cytokinesis [#3, #4]. ARF3 also controls collective cancer cell invasion modality and metastatic behavior by associating with and regulating turnover of N-cadherin [#8], and acts downstream of BIG1 in macrophages to drive PI(4,5)P2 synthesis and TIRAP recruitment that support TLR4-MyD88 inflammatory signaling [#5]. De novo missense variants in ARF3 that perturb GTP/GDP binding, GGA1 effector binding, and Golgi morphology cause a neurodevelopmental disorder, with both loss-of-function and gain-of-function alleles disrupting brain development in zebrafish and Drosophila models [#6, #7].\",\n  \"teleology\": [\n    {\n      \"year\": 1996,\n      \"claim\": \"Established that ARF3 nucleotide exchange is not spontaneous but catalyzed by a defined enzyme class, identifying a Sec7-domain GEP as the activator and explaining the brefeldin A sensitivity of ARF3-dependent trafficking.\",\n      \"evidence\": \"Protein purification of a ~200 kDa GEP from bovine brain cytosol with in vitro nucleotide exchange assays and tryptic peptide sequencing showing 47% identity to yeast Sec7\",\n      \"pmids\": [\"8917509\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not resolve which specific BIG-family GEF acts on ARF3 in cells\", \"Substrate specificity between ARF1 and ARF3 not distinguished\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Defined the structural determinants within ARF3 that control nucleotide exchange kinetics and effector binding, linking specific GDP-pocket residues to functional output.\",\n      \"evidence\": \"Site-directed mutagenesis of F51/W66/Y81 with in vitro nucleotide dissociation/association assays and yeast two-hybrid effector binding\",\n      \"pmids\": [\"11150519\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Effector identities defined only by two-hybrid, not in cells\", \"No structural model of the GDP-bound pocket provided\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Resolved how ARF3 is targeted to a specific membrane compartment, showing its TGN localization uniquely requires BIG GEFs and is governed by distinct residues controlling recruitment versus temperature-dependent release.\",\n      \"evidence\": \"siRNA knockdown of BIG GEFs with fluorescence microscopy, temperature-shift block, and ARF3 mutagenesis\",\n      \"pmids\": [\"20357002\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of temperature-dependent release not molecularly defined\", \"Functional consequence of ARF3-specific TGN targeting not addressed here\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Assigned ARF3 a functional role in endosomal recycling, showing it acts redundantly with ARF1 to maintain recycling endosome morphology and transferrin return to the plasma membrane.\",\n      \"evidence\": \"siRNA double knockdown of ARF1 and ARF3 with transferrin recycling, endocytosis, and retrograde transport assays plus compartment markers\",\n      \"pmids\": [\"22971977\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Redundancy prevents isolation of the ARF3-specific contribution\", \"Effectors mediating recycling endosome integrity not identified\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Extended ARF3 function to cell division, demonstrating class I ARFs localize to the Flemming body and are required for cytokinesis completion.\",\n      \"evidence\": \"Double and triple siRNA knockdown with Flemming body localization and multinucleate cell quantification\",\n      \"pmids\": [\"26330566\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"ARF3-specific contribution confounded by combined knockdowns\", \"Molecular partners at the Flemming body not identified\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Placed ARF3 in an inflammatory signaling axis, showing BIG1-driven ARF3 activation promotes PI(4,5)P2 synthesis and TIRAP recruitment supporting TLR4-MyD88 signaling.\",\n      \"evidence\": \"Myeloid-specific BIG1 knockout mouse and macrophage knockdowns with ARF3 activation, PI(4,5)P2, TIRAP recruitment, and cytokine assays\",\n      \"pmids\": [\"32415087\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct ARF3 KO epistasis not shown\", \"Mechanism linking ARF3 to PIP5K activation not biochemically resolved\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Connected ARF3 dysfunction to human disease, showing de novo variants perturbing the nucleotide-binding pocket and effector binding cause a neurodevelopmental disorder via both loss- and gain-of-function mechanisms.\",\n      \"evidence\": \"Cell-based Golgi/vesicle and nucleotide binding assays, GGA1 pull-downs, and Drosophila and zebrafish disease modeling across multiple variants\",\n      \"pmids\": [\"34346499\", \"36369169\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How distinct alleles produce convergent neurodevelopmental phenotypes unresolved\", \"Cell-type-specific requirements in human brain not defined\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Revealed a role for ARF3 in cancer cell behavior, identifying N-cadherin turnover as the mechanism by which ARF3 levels set collective invasion modality and metastatic potential.\",\n      \"evidence\": \"3D functional genomic screen with siRNA/overexpression, N-cadherin co-association and turnover assays, and intraprostatic in vivo tumor transplants\",\n      \"pmids\": [\"36880595\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct physical mode of ARF3-N-cadherin association not structurally defined\", \"Single-lab study not independently replicated\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Implicated ARF3 in viral pathogenesis, showing its knockdown suppresses influenza A replication and dampens inflammasome-driven lung injury.\",\n      \"evidence\": \"siRNA knockdown in vitro and mouse IAV pneumonia model with cytokine and NLRP3 inflammasome readouts\",\n      \"pmids\": [\"40608252\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No direct biochemical mechanism linking ARF3 to NLRP3 inflammasome\", \"Single-lab phenotypic study with limited pathway resolution\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How ARF3's distinct membrane localization and effector selectivity translate into its non-redundant roles in neurodevelopment, cancer invasion, and inflammation remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No structure of ARF3 with its GEFs or effectors in the timeline\", \"ARF3-specific (vs ARF1) effector repertoire not comprehensively mapped\", \"Causal chain from GTPase cycle to PI(4,5)P2 synthesis and N-cadherin turnover not biochemically reconstituted\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0003924\", \"supporting_discovery_ids\": [0, 1, 7]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005794\", \"supporting_discovery_ids\": [2, 6, 7]},\n      {\"term_id\": \"GO:0005768\", \"supporting_discovery_ids\": [3]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [6]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-5653656\", \"supporting_discovery_ids\": [2, 3]},\n      {\"term_id\": \"R-HSA-1640170\", \"supporting_discovery_ids\": [4]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [5]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [6, 7]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"BIG1\", \"GGA1\", \"N-cadherin\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":6,"faith_total":6,"faith_pct":100.0}}